Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.

about

Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.

Item

http://www.wikidata.org/entity/Q47849947

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@en

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@nl

type

Item

label

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@en

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@nl

prefLabel

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@en

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@nl

P1476

Prediction of cognitive worsen ...... e: Clinical use of biomarkers.

@en

P2093

Agnese Picco

http://www.w3.org/2001/XMLSchema#string

Andrea Brugnolo

http://www.w3.org/2001/XMLSchema#string

Francesco Famà

http://www.w3.org/2001/XMLSchema#string

Jennifer Accardo

http://www.w3.org/2001/XMLSchema#string

Luca Proietti

http://www.w3.org/2001/XMLSchema#string

Matteo Pardini

http://www.w3.org/2001/XMLSchema#string

Nicola Girtler

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in an aging and dementia cohort.

Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.

The epidemiology of dementia associated with Parkinson's disease.

Association between cognition and function in patients with Parkinson disease with and without dementia.

Predictors of dementia in Parkinson disease: a prospective cohort study.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Diagnostic criteria for Parkinson disease.

EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.

Quantitative EEG as a predictive biomarker for Parkinson disease dementia

P304

1738-1747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.27190

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29119593

http://www.w3.org/2001/XMLSchema#string